Brief: Allovir's Reverse Stock Split Proposal Passes With 96.2 Mln Votes For
10/01/2025 13:04
Jan 10 (Reuters) - Allovir Inc ALVR.O :
* ALLOVIR INC - REVERSE STOCK SPLIT PROPOSAL PASSES WITH
96.2
MILLION VOTES FOR, 12.1 MILLION AGAINST
Source text: https://shorturl.at/tlTx4
Further company coverage: ALVR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million